An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events

Abstract

OBJECTIVESOur aim was to study whether an insertion/deletion (I/D) polymorphism in the α2B-adrenoceptor gene is associated with the risk for cardiovascular diseases.BACKGROUNDα2-adrenoceptors mediate contraction of vascular smooth muscle and induce coronary vasoconstriction in humans. The α2-adrenoceptor subtype B mediates vasoconstriction in mice. A variant of the human α2B-adrenoceptor gene that encodes a D of three residues in an intracellular acidic motif has been shown to confer decreased receptor desensitization. This receptor variant could, therefore, be involved in diseases associated with enhanced vasoconstriction.METHODSThis study was part of a prospective population-based study investigating risk factors for cardiovascular diseases in a cohort of middle-aged men from eastern Finland. Nine hundred twelve men aged 46 to 64 years were followed for an average time of 4.5 years.RESULTSIn this study population, 192 men (21%) had the D/D genotype; 256 (28%) had the I/I genotype, and 464 (51%) had a heterozygous genotype. In a Cox model adjusting for other coronary risk factors, men with the D/D genotype had 2.2 times (95% confidence interval: 1.1 to 4.4, p = 0.02) the risk to experience an acute coronary event (n = 15 for D/D, 10 for I/I and 12 for I/D) compared with men carrying either of the other two genotypes. The α2B-adrenoceptor genotype was not associated with hypertension in this study population.CONCLUSIONSThe D/D genotype of the α2B-adrenoceptor is a novel genetic risk factor for acute coronary events, but not for hypertension.